Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity

@article{Merwat2008FulminantHF,
  title={Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity},
  author={Shehzad Nawaz Merwat and Wareef Kabbani and Douglas G. Adler},
  journal={Digestive Diseases and Sciences},
  year={2008},
  volume={54},
  pages={910-913}
}
We report the case of a 76-year-old man who developed fulminant hepatic failure after treatment with the antiandrogen nilutamide (Nilandron). Both reversible and fatal liver toxicity have been described in patients treated with flutamide, an analogue of nilutamide, although this has been less commonly described with nilutamide itself [1]. Our patient was prescribed nilutamide as part of combined androgen blockade. The patient’s liver biopsy was consistent with a drug-induced hepatitis. The… 
3 Citations
Sex hormones and related compounds, including hormonal contraceptives
TLDR
This chapter discusses sex hormones and related compounds including hormonal contraceptives, and Diethylstilbestrol has clearly been shown to cause primary vaginal carcinoma in the second generation and tumors continue to occur in women in middle age.
Current awareness: Pharmacoepidemiology and drug safety
  • 2009
In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography
Chapter 40 - Sex hormones and related compounds, including hormonal contraceptives
TLDR
There was no difference in the risk of myocardial infarction or stroke associated with current use of conjugated equine estrogens or esterified estrogens compared with no treatment, and the risks in the children of mothers who had been exposed in utero to diethylstilbestrol have been studied.

References

SHOWING 1-10 OF 17 REFERENCES
[Fatal fulminant hepatitis induced by nilutamide (Anandron)].
The first case of fatal fulminant hepatitis probably caused by nilutamide, a non steroidal antiandrogen derivative, is reported. Nilutamide administration had been continued for 6 days after the
Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project.
TLDR
The results indicate that nilutamide as a single agent has an acceptable toxicity and a moderate activity, and may maintain sexual interest in a discrete number of cases, and whether monotherapy with nonsteroidal antiandrogens offers a valid option in the palliation of advanced disease remains to be seen in comparative prospective trials.
Fatal and Nonfatal Hepatotoxicity Associated with Flutamide
TLDR
This article summarizes reports submitted to the Food and Drug Administration of patients with hepatotoxicity that may have been caused by flutamide and reviews reports that originated in domestic patient care settings.
Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer.
  • Mcleod
  • Medicine
    The oncologist
  • 1997
TLDR
Bicalutamide appears to have some advantage over flutamide and nilutamide in terms of tolerability, and the reverse is true for hot flashes, which are a side effect of castration.
Evaluation of efficacy and tolerability of Nilutamide and Buserelin in the treatment of advanced prostate cancer.
  • R. Migliari, R. Scarpa, +5 authors E. Usai
  • Medicine
    Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences
  • 1991
TLDR
Tolerability and efficacy of a combination therapy of a LHRH analogue (Buserelin) and a pure antiandrogen (Nilutamide) in a group of 15 patients with advanced prostate cancer (stage D) followed over a period of six months are evaluated.
Hépatite fulminante mortelle imputable au nilutamide (Anandron).
TLDR
L'evolution rapidement fatale a pu etre precipitee par the prise conjointe de phenobarbital par la prise de nilutamide, un anti-androgene utilise dans le traitement des cancers de the prostate.
Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients).
TLDR
The combination of nilutamide and orchidectomy has a beneficial effect on pain of metastatic origin, levels of tumour markers, the objective response of disease and the time to disease progression, and this treatment combination might also improve survival.
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial.
TLDR
Nilutamide and Orchiectomy constitute a more effective treatment for metastatic prostatic cancer than orchiectomy alone, and the adverse effects of nilutamide, usually minor, are outweighed by the significant improvements in most disease measures and progression-free survival.
Antiandrogens in the treatment of prostatic cancer.
TLDR
It is emphasized that not only is CPA of great value in the treatment of prostatic carcinoma, but it is also useful in determining the hormone dependency of the tumor which is indispensable before proceeding with hormone therapy.
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study.
TLDR
Results of this study suggest that Anandron may be a safe and effective treatment for patients with advanced prostatic cancer.
...
1
2
...